Zaurategrast
CAS No. 455264-31-0
Zaurategrast ( CDP-323;CDP 323;CDP323 )
Catalog No. M14541 CAS No. 455264-31-0
A potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 789 | Get Quote |
|
100MG | 1197 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZaurategrast
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.
-
DescriptionA potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist, an ester prodrug of CT-7758; is developed for the treatment of multiple sclerosis.Multiple Sclerosis Phase 2 Discontinued
-
SynonymsCDP-323;CDP 323;CDP323
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaInflammation/Immunology
-
IndicationMultiple Sclerosis
Chemical Information
-
CAS Number455264-31-0
-
Formula Weight521.41
-
Molecular FormulaC26H25BrN4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)[C@@H](NC1=C(Br)C(C12CCCCC2)=O)CC3=CC=C(NC4=NC=CC5=C4C=NC=C5)C=C3
-
Chemical NameL-Phenylalanine, N-(2-bromo-3-oxospiro[3.5]non-1-en-1-yl)-4-(2,7-naphthyridin-1-ylamino)- (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bailey, et al. Current Immunology Reviews, 2012, 8, 135-1402. Wolf C, et al. PLoS One. 2013;8(3):e58438.
3. Chanteux H, et al. Drug Metab Dispos. 2014 Jan;42(1):153-61.
3. Chanteux H, et al. Drug Metab Dispos. 2014 Jan;42(1):153-61.
molnova catalog
related products
-
iRGD peptide
iRGD peptide is a 9-amino acid cyclic peptide (sequence: CRGDKGPDC) and a molecular mimicry agent that was originally identified in an in vivo screening of phage display libraries in tumor-bearing mice.
-
Cyclo(RADfK)
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide.
-
GLPG-0187
GLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist.